Drugs & Targets EMA grants Orphan Drug designation for ICT01 as treatment for AML July 25, 2025Vol.51 No.29
Regulatory News ODAC nixes GSK’s Blenrep myeloma regimens, citing ocular toxicity, dosing, applicability to U.S. population July 18, 2025Vol.51 No.28By Jacquelyn Cobb and Sara Willa Ernst
Cancer Policy NIH says it’s moving away from animal-based models July 18, 2025Vol.51 No.28By Claire Marie Porter
Cancer Policy Trump threatens tariffs on Big Pharma by Aug. 1 July 18, 2025Vol.51 No.28By Claire Marie Porter
Cancer Policy CMS publishes Medicare physician fee schedule proposal July 18, 2025Vol.51 No.28By Claire Marie Porter
Cancer Policy CMS proposes policy to move away from hospital-based care July 18, 2025Vol.51 No.28By Claire Marie Porter
In Brief Jill Barnholtz-Sloan joins Emory Winship as chief administrative officer July 18, 2025Vol.51 No.28
In Brief Lynn Henry named associate director for COE at UMich Rogel Cancer Center July 18, 2025Vol.51 No.28
